Barbara Schütt
FZI Research Center for Information Technology(DE)
Publications by Year
Research Areas
Autonomous Vehicle Technology and Safety, Endometriosis Research and Treatment, Estrogen and related hormone effects, Uterine Myomas and Treatments, Traffic and Road Safety
Most-Cited Works
- → Pharmacodynamics and safety of the novel selective progesterone receptor modulator vilaprisan: a double-blind, randomized, placebo-controlled phase 1 trial in healthy women(2016)43 cited
- → Pharmacokinetic interaction between the CYP3A4 inhibitor ketoconazole and the hormone drospirenone in combination with ethinylestradiol or estradiol(2015)33 cited
- → Human studies on abecarnil a new beta‐carboline anxiolytic: safety, tolerability and preliminary pharmacological profile.(1993)27 cited
- → Effect of the Novel Selective Progesterone Receptor Modulator Vilaprisan on Ovarian Activity in Healthy Women(2017)26 cited
- → 1001 Ways of Scenario Generation for Testing of Self-driving Cars: A Survey(2023)21 cited
- → β-Carbolines as Tools in Memory Research: Human Data with the β-Carboline ZK 93426(1988)18 cited
- → Protein binding of active ingredients and comparison of serum ethinyl estradiol sex hormone-binding globulin, corticosteroid-binding globulin, and cortisol levels in women using a combination of gestodene/ ethinyl estradiol (Femovan) or a combination of desogestrel/ ethinyl estradiol (Marvelon) and single-dose ethinyl estradiol bioequivalence from both oral contraceptives(1990)17 cited
- → Influence of changes in the concentration of sex hormone-binding globulin in human serum on the protein binding of the contraceptive steroids levonorgestrel, 3-keto-desogestrel and gestodene(1994)12 cited
- Pharmacokinetics and acute toleration of the beta-carboline derivative abecarnil in man.(1990)
- Pharmacokinetics and serum protein binding of gestodene and 3-keto-desogestrel in women after single oral administration of two different contraceptive formulations.(1992)